Mirzania M, Khalili S, Hasanpoor A, Shamshiri AR. Anti-CD20 Antibody is Effective in the Patient with Refractory Amegakaryocytic Thrombocytopenia, 25 Months Follow up. Int J Hematol Oncol Stem Cell Res. 1;8(2):41-44.